115 results
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
28 May 24
Sol-Gel Announces Receipt of Nasdaq Minimum Price Notice
7:17am
in the United States, China, Europe or Israel; and (xv) loss or retirement of key executives and research scientists; (xvi) general market, political
424B3
SLGL
Sol-Gel Technologies Ltd
20 May 24
Prospectus supplement
4:05pm
, Europe or Israel; and (xv) loss or retirement of key executives and research scientists; (xvi) general market, political and economic conditions … retirement
TOTAL NON-CURRENT ASSETS
TOTAL ASSETS
Liabilities and shareholders' equity
CURRENT LIABILITIES:
Accounts payable
Other accounts payable
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
20 May 24
Sol-Gel Reports First Quarter 2024 Financial Results and Provides
7:15am
in the United States, China, Europe or Israel; and (xv) loss or retirement of key executives and research scientists; (xvi) general market, political …
Funds in respect of employee rights upon retirement
TOTAL NON-CURRENT ASSETS
TOTAL ASSETS
Liabilities and shareholders' equity
CURRENT LIABILITIES
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
16 May 24
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to
6:15am
) loss or retirement of key executives and research scientists; (xvi) general market, political and economic conditions in the countries in which
424B3
SLGL
Sol-Gel Technologies Ltd
4 Apr 24
Prospectus supplement
9:05am
and support the use of Twyneo, Epsolay and our product candidates; and
loss or retirement of key executives and research scientists.
You should review
6-K
EX-99.1
7k339uze
1 Apr 24
Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to
7:15am
POS AM
ndof393rbd456lhts q8
20 Mar 24
Prospectus update (post-effective amendment)
4:05pm
6-K
EX-99.1
w3e ly6wr6qc1
13 Mar 24
Sol-Gel Reports Full-Year 2023 Financial Results and 2023 - Corporate Highlights and Recent Developments
8:34am
6-K
EX-99.1
yg7314q1lz
30 Nov 23
Current report (foreign)
7:10am
424B3
5wyj1 7cl77si
9 Nov 23
Prospectus supplement
3:41pm
6-K
EX-99.1
79pegm9
9 Nov 23
Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update
7:15am
424B3
notv95
10 Aug 23
Prospectus supplement
7:20am
6-K
EX-99.2
2mmliigh9abzbv
10 Aug 23
Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update
7:10am
6-K
EX-99.1
x81mfc t56g
10 Aug 23
Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update
7:10am
6-K
EX-99.1
h80z3h dyt0
6 Jun 23
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to
7:15am
424B3
zxjjzbx2d
12 May 23
Prospectus supplement
9:15am
6-K
EX-99.1
zry79lkrvcrr85t3o86
12 May 23
Sol-Gel Technologies Reports First Quarter 2023 Financial Results and Provides
12:00am